aluates Reports

$ 0.0

Automative

Global Blood Plasma Fractionation Market Research Report 2026

Published Date: 2026-03-30

Report Code: QYRE-Auto-37Y9355

Global Blood Plasma Fractionation Market Insights and Forecast to 2028

BUY CHAPTERS

Global Blood Plasma Fractionation Market Research Report 2026

Code: QYRE-Auto-37Y9355

Report

2026-03-30

Pages:131

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CSL Limited

Grifols S A

Octapharma AG

BPL

Kedrion S p A

RAAS

Hualan Bio

Takeda

LFB Group

Biotest

CBPO

Tiantan Bio

Shuanglin Bio

Boya-Bio

Yuanda shuyang

Weiguang Bio

Nanyue Bio

KM Biologics

Blood Plasma Fractionation Market Size

The global Blood Plasma Fractionation market was valued at US$ 34510 million in 2025 and is anticipated to reach US$ 56850 million by 2032, at a CAGR of 7.5% from 2026 to 2032.

Blood Plasma Fractionation Market

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation. In this report, we mainly study the Blood Plasma Fractionation products, such as: Immune Globulin, Coagulation Factor, Albumin, etc.

Market Drivers:

Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the blood plasma fractionation market.

Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the plasma fractionation market.

Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for blood plasma fractionation to produce these therapies.

Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.

Market Challenges:

High Costs of Plasma-Derived Products: The complex and time-consuming process of plasma fractionation leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.

Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.

Stringent Regulatory Framework: Plasma fractionation is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.

Complex Manufacturing Process: The plasma fractionation process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.

The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.

The classification of Blood Plasma Fractionation includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.

North America is the largest consumption place, with a revenue market share nearly 40 % in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Blood Plasma Fractionation.

This report delivers a comprehensive overview of the global Blood Plasma Fractionation market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood Plasma Fractionation. The Blood Plasma Fractionation market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Blood Plasma Fractionation market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Blood Plasma Fractionation manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Blood Plasma Fractionation Market Report

Report Metric	Details
Report Name	Blood Plasma Fractionation Market
Accounted market size in 2025	US$ 34510 million
Forecasted market size in 2032	US$ 56850 million
CAGR	7.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Immune Globulin Coagulation Factor Albumin Other
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Blood Plasma Fractionation companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Blood Plasma Fractionation Market growing?

Ans: The Blood Plasma Fractionation Market witnessing a CAGR of 7.5% during the forecast period 2026-2032.

What is the Blood Plasma Fractionation Market size in 2032?

Ans: The Blood Plasma Fractionation Market size in 2032 will be US$ 56850 million.

What is the Blood Plasma Fractionation Market share by type?

Ans: In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Fractionation market.

What is the Blood Plasma Fractionation Market share by region?

Ans: North America is the largest consumption place, with a revenue market share nearly 40 % in 2023.

Who are the main players in the Blood Plasma Fractionation Market report?

Ans: The main players in the Blood Plasma Fractionation Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Blood Plasma Fractionation Market report?

Ans: The Applications covered in the Blood Plasma Fractionation Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Blood Plasma Fractionation Market report?

Ans: The Types covered in the Blood Plasma Fractionation Market report are Immune Globulin, Coagulation Factor, Albumin, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood Plasma Fractionation Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Immune Globulin

1.2.3 Coagulation Factor

1.2.4 Albumin

1.2.5 Other

1.3 Market by Application

1.3.1 Global Blood Plasma Fractionation Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Blood Plasma Fractionation Market Perspective (2021–2032)

2.2 Global Blood Plasma Fractionation Growth Trends by Region

2.2.1 Global Blood Plasma Fractionation Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Blood Plasma Fractionation Historic Market Size by Region (2021–2026)

2.2.3 Blood Plasma Fractionation Forecasted Market Size by Region (2027–2032)

2.3 Blood Plasma Fractionation Market Dynamics

2.3.1 Blood Plasma Fractionation Industry Trends

2.3.2 Blood Plasma Fractionation Market Drivers

2.3.3 Blood Plasma Fractionation Market Challenges

2.3.4 Blood Plasma Fractionation Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Blood Plasma Fractionation Players by Revenue

3.1.1 Global Top Blood Plasma Fractionation Players by Revenue (2021–2026)

3.1.2 Global Blood Plasma Fractionation Revenue Market Share by Players (2021–2026)

3.2 Global Top Blood Plasma Fractionation Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Blood Plasma Fractionation Revenue

3.4 Global Blood Plasma Fractionation Market Concentration Ratio

3.4.1 Global Blood Plasma Fractionation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Fractionation Revenue in 2025

3.5 Global Key Players of Blood Plasma Fractionation Head Offices and Areas Served

3.6 Global Key Players of Blood Plasma Fractionation, Products and Applications

3.7 Global Key Players of Blood Plasma Fractionation, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Blood Plasma Fractionation Breakdown Data by Type

4.1 Global Blood Plasma Fractionation Historic Market Size by Type (2021–2026)

4.2 Global Blood Plasma Fractionation Forecasted Market Size by Type (2027–2032)

5 Blood Plasma Fractionation Breakdown Data by Application

5.1 Global Blood Plasma Fractionation Historic Market Size by Application (2021–2026)

5.2 Global Blood Plasma Fractionation Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Blood Plasma Fractionation Market Size (2021–2032)

6.2 North America Blood Plasma Fractionation Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Blood Plasma Fractionation Market Size by Country (2021–2026)

6.4 North America Blood Plasma Fractionation Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Blood Plasma Fractionation Market Size (2021–2032)

7.2 Europe Blood Plasma Fractionation Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Blood Plasma Fractionation Market Size by Country (2021–2026)

7.4 Europe Blood Plasma Fractionation Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Blood Plasma Fractionation Market Size (2021–2032)

8.2 Asia-Pacific Blood Plasma Fractionation Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Blood Plasma Fractionation Market Size by Region (2021–2026)

8.4 Asia-Pacific Blood Plasma Fractionation Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Blood Plasma Fractionation Market Size (2021–2032)

9.2 Latin America Blood Plasma Fractionation Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Blood Plasma Fractionation Market Size by Country (2021–2026)

9.4 Latin America Blood Plasma Fractionation Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Blood Plasma Fractionation Market Size (2021–2032)

10.2 Middle East & Africa Blood Plasma Fractionation Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Blood Plasma Fractionation Market Size by Country (2021–2026)

10.4 Middle East & Africa Blood Plasma Fractionation Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Details

11.1.2 Takeda Business Overview

11.1.3 Takeda Blood Plasma Fractionation Introduction

11.1.4 Takeda Revenue in Blood Plasma Fractionation Business (2021–2026)

11.1.5 Takeda Recent Development

11.2 CSL

11.2.1 CSL Company Details

11.2.2 CSL Business Overview

11.2.3 CSL Blood Plasma Fractionation Introduction

11.2.4 CSL Revenue in Blood Plasma Fractionation Business (2021–2026)

11.2.5 CSL Recent Development

11.3 Grifols

11.3.1 Grifols Company Details

11.3.2 Grifols Business Overview

11.3.3 Grifols Blood Plasma Fractionation Introduction

11.3.4 Grifols Revenue in Blood Plasma Fractionation Business (2021–2026)

11.3.5 Grifols Recent Development

11.4 Octapharma

11.4.1 Octapharma Company Details

11.4.2 Octapharma Business Overview

11.4.3 Octapharma Blood Plasma Fractionation Introduction

11.4.4 Octapharma Revenue in Blood Plasma Fractionation Business (2021–2026)

11.4.5 Octapharma Recent Development

11.5 Kedrion

11.5.1 Kedrion Company Details

11.5.2 Kedrion Business Overview

11.5.3 Kedrion Blood Plasma Fractionation Introduction

11.5.4 Kedrion Revenue in Blood Plasma Fractionation Business (2021–2026)

11.5.5 Kedrion Recent Development

11.6 LFB Group

11.6.1 LFB Group Company Details

11.6.2 LFB Group Business Overview

11.6.3 LFB Group Blood Plasma Fractionation Introduction

11.6.4 LFB Group Revenue in Blood Plasma Fractionation Business (2021–2026)

11.6.5 LFB Group Recent Development

11.7 Biotest

11.7.1 Biotest Company Details

11.7.2 Biotest Business Overview

11.7.3 Biotest Blood Plasma Fractionation Introduction

11.7.4 Biotest Revenue in Blood Plasma Fractionation Business (2021–2026)

11.7.5 Biotest Recent Development

11.8 BPL

11.8.1 BPL Company Details

11.8.2 BPL Business Overview

11.8.3 BPL Blood Plasma Fractionation Introduction

11.8.4 BPL Revenue in Blood Plasma Fractionation Business (2021–2026)

11.8.5 BPL Recent Development

11.9 RAAS

11.9.1 RAAS Company Details

11.9.2 RAAS Business Overview

11.9.3 RAAS Blood Plasma Fractionation Introduction

11.9.4 RAAS Revenue in Blood Plasma Fractionation Business (2021–2026)

11.9.5 RAAS Recent Development

11.10 CBPO

11.10.1 CBPO Company Details

11.10.2 CBPO Business Overview

11.10.3 CBPO Blood Plasma Fractionation Introduction

11.10.4 CBPO Revenue in Blood Plasma Fractionation Business (2021–2026)

11.10.5 CBPO Recent Development

11.11 Hualan Bio

11.11.1 Hualan Bio Company Details

11.11.2 Hualan Bio Business Overview

11.11.3 Hualan Bio Blood Plasma Fractionation Introduction

11.11.4 Hualan Bio Revenue in Blood Plasma Fractionation Business (2021–2026)

11.11.5 Hualan Bio Recent Development

11.12 Tiantan Bio

11.12.1 Tiantan Bio Company Details

11.12.2 Tiantan Bio Business Overview

11.12.3 Tiantan Bio Blood Plasma Fractionation Introduction

11.12.4 Tiantan Bio Revenue in Blood Plasma Fractionation Business (2021–2026)

11.12.5 Tiantan Bio Recent Development

11.13 Shuanglin Bio

11.13.1 Shuanglin Bio Company Details

11.13.2 Shuanglin Bio Business Overview

11.13.3 Shuanglin Bio Blood Plasma Fractionation Introduction

11.13.4 Shuanglin Bio Revenue in Blood Plasma Fractionation Business (2021–2026)

11.13.5 Shuanglin Bio Recent Development

11.14 Boya Bio

11.14.1 Boya Bio Company Details

11.14.2 Boya Bio Business Overview

11.14.3 Boya Bio Blood Plasma Fractionation Introduction

11.14.4 Boya Bio Revenue in Blood Plasma Fractionation Business (2021–2026)

11.14.5 Boya Bio Recent Development

11.15 Yuanda Shuyang

11.15.1 Yuanda Shuyang Company Details

11.15.2 Yuanda Shuyang Business Overview

11.15.3 Yuanda Shuyang Blood Plasma Fractionation Introduction

11.15.4 Yuanda Shuyang Revenue in Blood Plasma Fractionation Business (2021–2026)

11.15.5 Yuanda Shuyang Recent Development

11.16 Weiguang Bio

11.16.1 Weiguang Bio Company Details

11.16.2 Weiguang Bio Business Overview

11.16.3 Weiguang Bio Blood Plasma Fractionation Introduction

11.16.4 Weiguang Bio Revenue in Blood Plasma Fractionation Business (2021–2026)

11.16.5 Weiguang Bio Recent Development

11.17 Nanyue Bio

11.17.1 Nanyue Bio Company Details

11.17.2 Nanyue Bio Business Overview

11.17.3 Nanyue Bio Blood Plasma Fractionation Introduction

11.17.4 Nanyue Bio Revenue in Blood Plasma Fractionation Business (2021–2026)

11.17.5 Nanyue Bio Recent Development

11.18 KM Biologics

11.18.1 KM Biologics Company Details

11.18.2 KM Biologics Business Overview

11.18.3 KM Biologics Blood Plasma Fractionation Introduction

11.18.4 KM Biologics Revenue in Blood Plasma Fractionation Business (2021–2026)

11.18.5 KM Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

CSL Limited

Grifols S A

Octapharma AG

BPL

Kedrion S p A

RAAS

Hualan Bio

Takeda

LFB Group

Biotest

CBPO

Tiantan Bio

Shuanglin Bio

Boya-Bio

Yuanda shuyang

Weiguang Bio

Nanyue Bio

KM Biologics

List of Tables

Table 1. Global Blood Plasma Fractionation Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Immune Globulin

Table 3. Key Players of Coagulation Factor

Table 4. Key Players of Albumin

Table 5. Key Players of Other

Table 6. Global Blood Plasma Fractionation Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Blood Plasma Fractionation Market Size by Region (US$ Million), 2021–2026

Table 9. Global Blood Plasma Fractionation Market Share by Region (2021–2026)

Table 10. Global Blood Plasma Fractionation Forecasted Market Size by Region (US$ Million), 2027–2032

Table 11. Global Blood Plasma Fractionation Market Share by Region (2027–2032)

Table 12. Blood Plasma Fractionation Market Trends

Table 13. Blood Plasma Fractionation Market Drivers

Table 14. Blood Plasma Fractionation Market Challenges

Table 15. Blood Plasma Fractionation Market Restraints

Table 16. Global Blood Plasma Fractionation Revenue by Players (US$ Million), 2021–2026

Table 17. Global Blood Plasma Fractionation Market Share by Players (2021–2026)

Table 18. Global Top Blood Plasma Fractionation Players by Tier (Tier 1, Tier 2, and Tier 3), based on Blood Plasma Fractionation Revenue, 2025

Table 19. Ranking of Global Top Blood Plasma Fractionation Companies by Revenue (US$ Million) in 2025

Table 20. Global 5 Largest Players Market Share by Blood Plasma Fractionation Revenue (CR5 and HHI), 2021–2026

Table 21. Global Key Players of Blood Plasma Fractionation, Headquarters and Area Served

Table 22. Global Key Players of Blood Plasma Fractionation, Products and Applications

Table 23. Global Key Players of Blood Plasma Fractionation, Date of General Availability (GA)

Table 24. Mergers and Acquisitions, Expansion Plans

Table 25. Global Blood Plasma Fractionation Market Size by Type (US$ Million), 2021–2026

Table 26. Global Blood Plasma Fractionation Revenue Market Share by Type (2021–2026)

Table 27. Global Blood Plasma Fractionation Forecasted Market Size by Type (US$ Million), 2027–2032

Table 28. Global Blood Plasma Fractionation Revenue Market Share by Type (2027–2032)

Table 29. Global Blood Plasma Fractionation Market Size by Application (US$ Million), 2021–2026

Table 30. Global Blood Plasma Fractionation Revenue Market Share by Application (2021–2026)

Table 31. Global Blood Plasma Fractionation Forecasted Market Size by Application (US$ Million), 2027–2032

Table 32. Global Blood Plasma Fractionation Revenue Market Share by Application (2027–2032)

Table 33. North America Blood Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 34. North America Blood Plasma Fractionation Market Size by Country (US$ Million), 2021–2026

Table 35. North America Blood Plasma Fractionation Market Size by Country (US$ Million), 2027–2032

Table 36. Europe Blood Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 37. Europe Blood Plasma Fractionation Market Size by Country (US$ Million), 2021–2026

Table 38. Europe Blood Plasma Fractionation Market Size by Country (US$ Million), 2027–2032

Table 39. Asia-Pacific Blood Plasma Fractionation Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 40. Asia-Pacific Blood Plasma Fractionation Market Size by Region (US$ Million), 2021–2026

Table 41. Asia-Pacific Blood Plasma Fractionation Market Size by Region (US$ Million), 2027–2032

Table 42. Latin America Blood Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Latin America Blood Plasma Fractionation Market Size by Country (US$ Million), 2021–2026

Table 44. Latin America Blood Plasma Fractionation Market Size by Country (US$ Million), 2027–2032

Table 45. Middle East & Africa Blood Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Middle East & Africa Blood Plasma Fractionation Market Size by Country (US$ Million), 2021–2026

Table 47. Middle East & Africa Blood Plasma Fractionation Market Size by Country (US$ Million), 2027–2032

Table 48. Takeda Company Details

Table 49. Takeda Business Overview

Table 50. Takeda Blood Plasma Fractionation Product

Table 51. Takeda Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 52. Takeda Recent Development

Table 53. CSL Company Details

Table 54. CSL Business Overview

Table 55. CSL Blood Plasma Fractionation Product

Table 56. CSL Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 57. CSL Recent Development

Table 58. Grifols Company Details

Table 59. Grifols Business Overview

Table 60. Grifols Blood Plasma Fractionation Product

Table 61. Grifols Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 62. Grifols Recent Development

Table 63. Octapharma Company Details

Table 64. Octapharma Business Overview

Table 65. Octapharma Blood Plasma Fractionation Product

Table 66. Octapharma Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 67. Octapharma Recent Development

Table 68. Kedrion Company Details

Table 69. Kedrion Business Overview

Table 70. Kedrion Blood Plasma Fractionation Product

Table 71. Kedrion Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 72. Kedrion Recent Development

Table 73. LFB Group Company Details

Table 74. LFB Group Business Overview

Table 75. LFB Group Blood Plasma Fractionation Product

Table 76. LFB Group Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 77. LFB Group Recent Development

Table 78. Biotest Company Details

Table 79. Biotest Business Overview

Table 80. Biotest Blood Plasma Fractionation Product

Table 81. Biotest Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 82. Biotest Recent Development

Table 83. BPL Company Details

Table 84. BPL Business Overview

Table 85. BPL Blood Plasma Fractionation Product

Table 86. BPL Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 87. BPL Recent Development

Table 88. RAAS Company Details

Table 89. RAAS Business Overview

Table 90. RAAS Blood Plasma Fractionation Product

Table 91. RAAS Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 92. RAAS Recent Development

Table 93. CBPO Company Details

Table 94. CBPO Business Overview

Table 95. CBPO Blood Plasma Fractionation Product

Table 96. CBPO Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 97. CBPO Recent Development

Table 98. Hualan Bio Company Details

Table 99. Hualan Bio Business Overview

Table 100. Hualan Bio Blood Plasma Fractionation Product

Table 101. Hualan Bio Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 102. Hualan Bio Recent Development

Table 103. Tiantan Bio Company Details

Table 104. Tiantan Bio Business Overview

Table 105. Tiantan Bio Blood Plasma Fractionation Product

Table 106. Tiantan Bio Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 107. Tiantan Bio Recent Development

Table 108. Shuanglin Bio Company Details

Table 109. Shuanglin Bio Business Overview

Table 110. Shuanglin Bio Blood Plasma Fractionation Product

Table 111. Shuanglin Bio Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 112. Shuanglin Bio Recent Development

Table 113. Boya Bio Company Details

Table 114. Boya Bio Business Overview

Table 115. Boya Bio Blood Plasma Fractionation Product

Table 116. Boya Bio Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 117. Boya Bio Recent Development

Table 118. Yuanda Shuyang Company Details

Table 119. Yuanda Shuyang Business Overview

Table 120. Yuanda Shuyang Blood Plasma Fractionation Product

Table 121. Yuanda Shuyang Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 122. Yuanda Shuyang Recent Development

Table 123. Weiguang Bio Company Details

Table 124. Weiguang Bio Business Overview

Table 125. Weiguang Bio Blood Plasma Fractionation Product

Table 126. Weiguang Bio Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 127. Weiguang Bio Recent Development

Table 128. Nanyue Bio Company Details

Table 129. Nanyue Bio Business Overview

Table 130. Nanyue Bio Blood Plasma Fractionation Product

Table 131. Nanyue Bio Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 132. Nanyue Bio Recent Development

Table 133. KM Biologics Company Details

Table 134. KM Biologics Business Overview

Table 135. KM Biologics Blood Plasma Fractionation Product

Table 136. KM Biologics Revenue in Blood Plasma Fractionation Business (US$ Million), 2021–2026

Table 137. KM Biologics Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Blood Plasma Fractionation Picture

Figure 2. Global Blood Plasma Fractionation Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Blood Plasma Fractionation Market Share by Type: 2025 vs 2032

Figure 4. Immune Globulin Features

Figure 5. Coagulation Factor Features

Figure 6. Albumin Features

Figure 7. Other Features

Figure 8. Global Blood Plasma Fractionation Market Size by Application (US$ Million), 2021–2032

Figure 9. Global Blood Plasma Fractionation Market Share by Application: 2025 vs 2032

Figure 10. Hospital Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Other Case Studies

Figure 13. Blood Plasma Fractionation Report Years Considered

Figure 14. Global Blood Plasma Fractionation Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Blood Plasma Fractionation Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Blood Plasma Fractionation Market Share by Region: 2025 vs 2032

Figure 17. Global Blood Plasma Fractionation Market Share by Players in 2025

Figure 18. Global Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Blood Plasma Fractionation Revenue in 2025

Figure 20. North America Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Blood Plasma Fractionation Market Share by Country (2021–2032)

Figure 22. United States Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Blood Plasma Fractionation Market Share by Country (2021–2032)

Figure 26. Germany Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Blood Plasma Fractionation Market Share by Region (2021–2032)

Figure 34. China Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Blood Plasma Fractionation Market Share by Country (2021–2032)

Figure 42. Mexico Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Blood Plasma Fractionation Market Share by Country (2021–2032)

Figure 46. Israel Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Blood Plasma Fractionation Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Takeda Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 50. CSL Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 51. Grifols Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 52. Octapharma Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 53. Kedrion Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 54. LFB Group Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 55. Biotest Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 56. BPL Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 57. RAAS Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 58. CBPO Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 59. Hualan Bio Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 60. Tiantan Bio Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 61. Shuanglin Bio Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 62. Boya Bio Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 63. Yuanda Shuyang Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 64. Weiguang Bio Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 65. Nanyue Bio Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 66. KM Biologics Revenue Growth Rate in Blood Plasma Fractionation Business (2021–2026)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Plasma Fractionation Technology Market Research Report 2025

Global Human Plasma Fractionation Product Market Research Report 2024

Global Human Blood Plasma Fractionation Market Research Report 2025

Global Human Plasma Protein Products Market Research Report 2024

Global Plasma derived Medical Product Market Research Report 2025

Global Plasma Fractionation Market Research Report 2025

Plasma Fractionation and Blood Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plasma Fractionation Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fractionated Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plasma for Fractionation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plasma derived Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Plasma Products and Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Biological Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Blood Product Market Insights Forecast to 2030

Global Blood Plasma Fractionators Market Research Report 2025

Global Plasma Protein Therapeutics Market Research Report 2025

Global Blood Banking and Blood Products Market Research Report 2024

Plasma Processing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions